Q3 2018 Holdings
Filed 2018-11-13 | 212 holdings | $297.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Assertio Therapeutics, Inc.(DEPOEUR) | Common | 04545L107 | $6 | 1,000 | 0.0% |
| Celldex Therapeutics, Inc. | Common | 15117B103 | $48 | 105,800 | 0.0% |
| Jounce Therapeutics, Inc.(JNCEEUR) | Common | 481116101 | $66 | 10,127 | 0.0% |
| Quorum Health Corporation | Common | 74909E106 | $139 | 23,725 | 0.0% |
| Intersect ENT, Inc. | Common | 46071F103 | $240 | 8,356 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $244 | 24,784 | 0.0% |
| NuCana plc | Sponsored ADR | 67022C106 | $245 | 9,823 | 0.0% |
| Theravance Biopharma, Inc.(TBPH) | Common | G8807B106 | $264 | 8,083 | 0.0% |
| Eidos Therapeutics, Inc.(EIDXGBP) | Common | 28249H104 | $278 | 27,900 | 0.0% |
| Cardinal Health, Inc.(CAH) | Common | 14149Y108 | $340 | 6,300 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | Common | 079481107 | $370 | 60,000 | 0.0% |
| Alliqua BioMedical, Inc. | Common | 019621309 | $375 | 165,000 | 0.0% |
| Teligent, Inc. | Common | 87960W104 | $401 | 101,458 | 0.0% |
| Arca biopharma, Inc. | Common | 00211Y407 | $454 | 811,227 | 0.0% |
| NewLink Genetics Corporation | Common | 651511107 | $490 | 205,026 | 0.0% |
| The RMR Group Inc.(RMR) | Class A | 74967R106 | $494 | 5,323 | 0.0% |
| Clearside Biomedical, Inc.(CLSDUSD) | Common | 185063104 | $508 | 82,665 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | Common | 60468T105 | $640 | 13,590 | 0.0% |
| Global Medical REIT Inc.(GMREUSD) | Common | 37954A204 | $691 | 73,400 | 0.0% |
| Cidara Therapeutics, Inc. | Common | 171757107 | $699 | 158,784 | 0.0% |
| Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | $700 | $7,000,000 | 0.0% |
| Athenex, Inc.(ATNXEUR) | Common | 04685N103 | $708 | 45,530 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | Sponsored ADR | 76243J105 | $726 | 24,890 | 0.0% |
| Endocyte, Inc. | Common | 29269A102 | $746 | 41,980 | 0.0% |
| Lexicon Pharmaceuticals, Inc.(LXRX) | Sponsored ADR | 528872302 | $747 | 70,000 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | Common | 46116X101 | $756 | 34,850 | 0.0% |
| Molecular Templates, Inc. | Common | 608550109 | $777 | 144,110 | 0.0% |
| LivaNova plc(LIVN) | Shares | G5509L101 | $779 | 6,287 | 0.0% |
| Hologic, Inc.(HOLX) | Common | 436440101 | $801 | 19,546 | 0.0% |
| LeMaitre Vascular, Inc.(LMAT) | Common | 525558201 | $1.1K | 27,150 | 0.0% |
| Novavax, Inc. | Common | 670002104 | $1.1K | 571,000 | 0.0% |
| Affimed NV | Common | N01045108 | $1.1K | 254,000 | 0.0% |
| HCP, Inc. | Common | 40414L109 | $1.2K | 45,500 | 0.0% |
| Spark Therapeutics, Inc. | Common | 84652J103 | $1.2K | 22,046 | 0.0% |
| Healthcare Trust of America, Inc. | Common | 42225P501 | $1.2K | 46,000 | 0.0% |
| Concert Pharmaceuticals, Inc.(CNCEEUR) | Common | 206022105 | $1.3K | 90,724 | 0.0% |
| uniQure N.V.(QURE) | Shares | N90064101 | $1.4K | 37,741 | 0.0% |
| AC Immune SA(ACIU) | Shares | H00263105 | $1.4K | 171,813 | 0.0% |
| NuVasive, Inc.(NUVAGBP) | Common | 670704105 | $1.4K | 19,580 | 0.0% |
| ArQule, Inc.(ARQLUSD) | Common | 04269E107 | $1.4K | 250,000 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | Common | 558868105 | $1.4K | 6,670 | 0.0% |
| Koninklijke Philips N.V.(PHG) | NY Reg Sh | 500472303 | $1.5K | 33,100 | 0.0% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common | 05070R104 | $1.5K | 38,740 | 0.0% |
| Mallinckrodt plc | Shares | G5785G107 | $1.6K | 53,600 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | Common | 45253H101 | $1.6K | 168,190 | 0.0% |
| Syndax Pharmaceuticals, Inc.(SNDX) | Common | 87164F105 | $1.6K | 200,000 | 0.0% |
| Abiomed, Inc.(ABMDEUR) | Common | 003654100 | $1.7K | 3,750 | 0.0% |
| Teleflex Incorporated(TFX) | Common | 879369106 | $1.7K | 6,379 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | Common | 00448Q201 | $1.7K | 464,761 | 0.0% |
| Inovalon Holdings, Inc.(INOV) | Common | 45781D101 | $1.8K | 176,163 | 0.0% |